Literature DB >> 6133529

Benzodiazepines in the treatment of depressive, borderline personality, and schizophrenic disorders.

A F Schatzberg, J O Cole.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6133529      PMCID: PMC1401646          DOI: 10.1111/j.1365-2125.1981.tb01834.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  37 in total

1.  Intravenous diazepam in the treatment of neuroleptic-induced acute dystonia and akathisia.

Authors:  D Gagrat; J Hamilton; R H Belmaker
Journal:  Am J Psychiatry       Date:  1978-10       Impact factor: 18.112

2.  The chronic depressive in the community: unrecognized and poorly treated.

Authors:  M M Weissman; G L Klerman
Journal:  Compr Psychiatry       Date:  1977 Nov-Dec       Impact factor: 3.735

3.  Low-dose neuroleptic regimens in the treatment of borderline patients.

Authors:  J R Brinkley; B D Beitman; R O Friedel
Journal:  Arch Gen Psychiatry       Date:  1979-03

4.  A controlled study of placebo, chlordiazepoxide and chlorpromazine with thirty male schizophrenic patients.

Authors:  L J Hekimian; A J Friedhoff
Journal:  Dis Nerv Syst       Date:  1967-10

5.  A controlled comparison of diazepam and amylobarbitone in anxiety states.

Authors:  A McDowall; S Owen; A A Robin
Journal:  Br J Psychiatry       Date:  1966-06       Impact factor: 9.319

6.  Combined phenothiazine, chlordiazepoxide and primidone therapy for uncontrolled psychotic patients.

Authors:  R R Monroe; S P Wise
Journal:  Am J Psychiatry       Date:  1965-12       Impact factor: 18.112

7.  The borderline patient. A comparative analysis of four sets of diagnostic criteria.

Authors:  J C Perry; G L Klerman
Journal:  Arch Gen Psychiatry       Date:  1978-02

8.  Benzodiazepines in depressive disorders.

Authors:  A F Schatzberg; J O Cole
Journal:  Arch Gen Psychiatry       Date:  1978-11

9.  A placebo-controlled multicenter trial of Limbitrol versus its components (amitriptyline and chlordiazepoxide) in the symptomatic treatment of depressive illness.

Authors:  J P Feighner; B Brauzer; A J Gelenberg; E Gomez; A Kiev; M L Kurland; B L Weiss
Journal:  Psychopharmacology (Berl)       Date:  1979-03-22       Impact factor: 4.530

10.  Depressive classification and prediction of response to phenelzine.

Authors:  E S Paykel; R R Parker; R J Penrose; E R Rassaby
Journal:  Br J Psychiatry       Date:  1979-06       Impact factor: 9.319

View more
  3 in total

1.  The use of benzodiazepines in depression.

Authors:  D A Johnson
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

2.  Alprazolam in the treatment of generalized anxiety and panic disorders: a double-blind placebo-controlled study.

Authors:  G Chouinard; L Annable; R Fontaine; L Solyom
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

3.  Treatment of depressive outpatients with lorazepam, alprazolam, amytriptyline and placebo.

Authors:  G Laakman; M Faltermaier-Temizel; S Bossert-Zaudig; T Baghai; G Lorkowski
Journal:  Psychopharmacology (Berl)       Date:  1995-07       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.